Filing metadata

Accession number
0000950170-24-022413
Form type
Form 4
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Feb 28, 2024
Reporting period
Feb 26, 2024
Description
Insider transaction

Explore SEC Filings Hub